Programs Opioids Clinical Primer Resources Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline
Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline

Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline

Evidence, Guidelines and Recommendations

The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario. Provided by the Centre for Addiction and Mental Health (CAMH) and the College of Physicians and Surgeons of Ontario (CPSO)

Details

Category
Evidence, Guidelines and Recommendations
Format
PDF Document
File Size
1.40 MB
Downloads
3
Added
Aug 25, 2025
Tags
Psychiatry
Pain
Mental Health
Substance Use Disorders
Primary Care
Internal Medicine
Emergency Medicine

Related Resources

Health Quality Ontario Standards: Opioid Prescribing for Acute Pain
This quality standard includes: quality statements, patient reference guide, recommendations for adoption and a getting started guide
Health Quality Ontario Standards: Opioid Use Disorder (Opioid Addiction)
This quality standard includes: quality statements, patient reference guide, recommendations for adoption and a getting started guide.
Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).

Learn more

Stay up to date

News and updates direct to your inbox.

© 2025 McMaster University & Others | 1280 Main St. W. | Hamilton, Ontario L8S 4L8 | Terms of Use